Co-Diagnostics, Inc., a molecular diagnostics company, will be hosting a booth at the 17th Annual Next Generation Dx Summit in Washington, D.C. from August 18-20, 2025. Attendees can learn about the Co-Dx Logix Smart® suite of clinical laboratory solutions, the upcoming Co-Dx PCR diagnostics platform, and the company's pipeline of tests for upper respiratory, tuberculosis, and HPV, which are expected to enter clinical evaluations in 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA53283) on August 18, 2025, and is solely responsible for the information contained therein.